Mode
Text Size
Log in / Sign up
N/A Completed N=102 Randomized Single-blind Treatment

Retardation of Myopia in Orthokeratology

Source: ClinicalTrials.gov NCT00962208 ↗
Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Sep 2013
Primary outcomePrimary: Axial Elongation in the Study and Control Subjects Who Completed the Two Years Study — 0.36; 0.63 mm

Summary

The primary aim of this study is to evaluate and compare the eyeball elongation in children wearing orthokeratology lenses and single-vision spectacles.

Outcome Measures

OutcomeResultp-value
PRIMARY
Axial Elongation in the Study and Control Subjects Who Completed the Two Years Study
0.36; 0.63 —
SECONDARY
Determine the Incidence of Adverse Effects in Cornea, the Palpebral, Bulbar and Tarsal Conjunctiva in the Study and the Control Groups
— —
SECONDARY
Determine Changes in Other Ocular Parameters (e.g. Corneal Biomechanics and Aberration) Associated With Orthokeratology Lens Wear
— —

Eligibility Criteria

Inclusion Criteria

  • Myopia (refractive sphere): > 0.50D and ≤ 4.00D
  • Astigmatism: 0.75D and ≤ 4.50D
  • Anisometropia: ≤ 1.50D in both refractive sphere, refractive cylinder and SE
  • Best corrected monocular visual acuity: equal to or better than 0.10 in logMAR scale in both eyes
  • Willingness for randomization
  • Willingness to wear contact lenses or spectacles on a daily basis
  • Availability for follow-up for at least 2 years

Exclusion Criteria

  • Strabismus at distance or near
  • Contraindication for contact lens wear and orthokeratology (e.g. limbus to limbus corneal cylinder and dislocated corneal apex
  • Prior experience with the use of rigid lenses (including orthokeratology)
  • Prior experience with myopia control treatment (e.g. refractive therapy or progressive add spectacles)
  • Systemic or ocular conditions which may affect contact lens wear (e.g. allergy and medication)
  • Systemic or ocular conditions which may affect refractive development (e.g. Down syndrome, ptosis)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00962208). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search